视神经脊髓炎谱系疾病与多发性硬化患者的骨折风险:韩国全国性队列研究
该回顾性队列研究基于韩国国民健康保险服务数据库(2010年1月至2017年12月),纳入无骨折的多发性硬化(MS)患者1217例和视神经脊髓炎谱系疾病(NMOSD)患者1329例,并按年龄、性别及高血压、糖尿病、血脂异常匹配对照。结果显示,MS和NMOSD患者任何骨折、髋部骨折和椎体骨折的风险均高于对照,但两组间骨折发生率无显著差异。
要点
- MS患者任何骨折、髋部骨折和椎体骨折的校正风险比分别为1.81、3.36和2.01。
- NMOSD患者任何骨折、髋部骨折和椎体骨折的校正风险比分别为1.85、3.82和2.84。
- MS与NMOSD两组间骨折发生率无显著差异。
核心结论
- MS和NMOSD患者骨折风险约为匹配对照的1.8倍,髋部骨折风险尤其高(3至4倍)。
- 临床医生需定期评估MS/NMOSD患者的骨折风险并采取预防措施。
研究设计与样本
- 回顾性队列研究,分析韩国国民健康保险服务数据库2010年1月至2017年12月数据。
- 纳入索引日期无骨折的MS患者1217例和NMOSD患者1329例,按年龄、性别及高血压、糖尿病、血脂异常匹配对照。
- MS/NMOSD患者索引日期后平均随访时间分别为4.40年和4.08年,匹配对照分别为4.73年和4.28年。
主要发现
- MS患者任何骨折、髋部骨折和椎体骨折的校正风险比(95%CI)分别为1.81(1.43-2.28)、3.36(1.81-6.24)和2.01(1.42-2.99)。
- NMOSD患者任何骨折、髋部骨折和椎体骨折的校正风险比(95%CI)分别为1.85(1.47-2.34)、3.82(2.05-7.11)和2.84(1.92-4.21)。
- MS与NMOSD两组间骨折发生率无显著差异。
临床怎么用
- 作者结论指出,临床医生需定期评估MS/NMOSD患者的骨折风险并采取预防措施以降低风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Interest in fractures in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) has considerably increased in the last decade. However, few studies have compared the incidence of fractures between patients with MS and NMOSD using a nationwide database. This study aimed to evaluate the differences in the risk of fracture between patients with NMOSD and MS compared to that in healthy controls using cohort data from a Korean nationwide database. METHODS: In this retrospective cohort study, data from the National Health Insurance Service (NHIS) database from January 2010 to December 2017 were analyzed. A total of 1,217/1,329 patients with MS/NMOSD free of fractures at the index date were included. Matched controls were selected based on age, sex, and the presence of hypertension, diabetes mellitus, and dyslipidemia. The mean follow-up durations after the index date were 4.40/4.08 years for patients with MS/NMOSD and 4.73/4.28 for their matched controls. RESULTS: The adjusted hazard ratios (aHRs) with 95% confidence intervals of any, hip, and vertebral fractures were 1.81 (1.43-2.28), 3.36 (1.81-6.24), and 2.01 (1.42-2.99) times higher for patients with MS than for controls, respectively, and they were 1.85 (1.47-2.34), 3.82 (2.05-7.11), and 2.84 (1.92-4.21) times higher for patients with NMOSD than for controls, respectively. No significant differences were observed in the incidence of fractures between the MS and NMOSD groups. Patients with MS/NMOSD had a 1.8-fold higher risk of fracture than matched controls, and the risk of hip fracture was especially high (3- to 4-fold higher). CONCLUSIONS: Clinicians need to regularly assess patients with MS/NMOSD for the risk of fractures and take preventative measures to reduce it.
引用
- Jung SY, Cho EB, Han KD, et al. Risk of fracture in neuromyelitis optica spectrum disorder and multiple sclerosis: a nationwide cohort study in South Korea. Osteoporos Int. 2023. PMID: 36854747. doi:10.1007/s00198-023-06715-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。